
Consider a long-term investment in GLP-1 drug manufacturers Novo Nordisk (NVO) and Eli Lilly (LLY), which have strong expert endorsement and are demonstrating a measurable public health impact. Conversely, investors should be cautious of companies reliant on ultra-processed foods, such as Kraft Heinz (KHC), which face significant risk from shifting consumer preferences toward healthier options. Shopify (SHOP) remains a high-conviction investment, positioned as a dominant platform benefiting from the continued growth of e-commerce. For a more targeted play on the healthy meal delivery trend, consider HelloFresh (HFG), the parent company of the growing Factor brand.

By Next Big Idea Club
The Next Big Idea is a weekly series of in-depth interviews with the world’s leading thinkers. Join hosts Rufus Griscom and Caleb Bissinger — along with our curators, Malcolm Gladwell, Adam Grant, Susan Cain, and Daniel Pink — for conversations that might just change the way you see the world. New episodes every Thursday.